The impact of cytochrome 450 and Paraoxonase polymorphisms on clopidogrel resistance and major adverse cardiac events in coronary heart disease patients after percutaneous coronary intervention

BACKGROUND: Clopidogrel is an inactive prodrug, it catalyzed into its active form by Cytochrome 450 and Paraoxonase-1(PON-1). polymorphisms of genes encoding these enzymes will affect the efficacy of Clopidogrel. The main objective of our study was to investigate the association of CYP2C19*2, CYP2C1...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhaowei, Chen, Mingxiao, Zhang, Long, Zhao, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942367/
https://www.ncbi.nlm.nih.gov/pubmed/31900240
http://dx.doi.org/10.1186/s40360-019-0378-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942367/
https://www.ncbi.nlm.nih.gov/pubmed/31900240
http://dx.doi.org/10.1186/s40360-019-0378-7

Ejemplares similares